FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation

Bibliographic Details
Main Authors:	Jordan McDonald, BA, Chine-Yu Chuang, BA, J. Kevin Hicks, PharmD, PhD, Darcy K. Berry, MS, CGC, Iman Imanirad, MD, Anupam Rishi, MD, Jessica M. Frakes, MD, Sarah E. Hoffe, MD, Seth Felder, MD
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109421000750

Similar Items

Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management
by: Leila T. Tchelebi MD, et al.
Published: (2020-10-01)

A Case of Radiation Recall Myositis and Neuropathy in Locally Advanced Rectal Cancer
by: Charles T. Lee, MD, PharmD, et al.
Published: (2021-11-01)

Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study
by: Piero Del Boccio, PhD, et al.
Published: (2017-04-01)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
by: Shalini Moningi, MD, et al.
Published: (2020-05-01)

Effect of Carbogen to Chemoradiation in Volume of Rectal Cancer
by: Christina Hari Nawangsih, et al.
Published: (2020-06-01)

A concise clinician’s guide to therapy for hidradenitis suppurativa
by: Emily Nesbitt, BA, et al.
Published: (2020-03-01)

Conventional chemoradiation with Cisplatin Versus hemoradiation with Cisplatin plus Gemcitabine in uterine cervical cancer
by: Ahmad Ameri (MD), et al.
Published: (2008-10-01)

Chemoradiation therapy with docetaxel in elderly patients with stage II/III esophageal cancer: A phase 2 trial
by: Akihiro Ohba, MD, et al.
Published: (2016-10-01)

Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiation
by: Brian P. Hibler, MD, et al.
Published: (2017-05-01)

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution
by: Nikhil Yegya-Raman, MD, et al.
Published: (2019-07-01)

Feasibility of definitive chemoradiation therapy with nedaplatin and 5-fluorouracil in elderly patients with esophageal squamous cell carcinoma: A retrospective study
by: Akinori Watanabe, MD, et al.
Published: (2018-07-01)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
by: Raquel Conde-Muíño, et al.
Published: (2015-01-01)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
by: Greg D. Judy, MD, et al.
Published: (2018-07-01)

18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation
by: John M. David, MD, et al.
Published: (2019-10-01)

Influence of Caregiver Presence During Physician Office Visits on Patients Undergoing Chemoradiation Therapy for Esophageal Cancer
by: Joseph K. Ho, MD, et al.
Published: (2021-03-01)

PHYSIOLOGICALLY-INSPIRED RADIOMICS OF THE RECTAL ENVIRONMENT FOR PREDICTING AND EVALUATING RESPONSE TO CHEMORADIATION IN RECTAL CANCERS
by: Antunes, Jacob T., Antunes
Published: (2020)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
by: Leo Y. Luo, MD, et al.
Published: (2021-01-01)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
by: Sarah Z. Hazell, MD, et al.
Published: (2020-03-01)

FANCD2 and DNA Damage
by: Manoj Nepal, et al.
Published: (2017-08-01)

The FANCD2–FANCI complex is recruited to DNA interstrand crosslinks before monoubiquitination of FANCD2
by: Chih-Chao Liang, et al.
Published: (2016-07-01)

Biomarkers and Mechanisms of FANCD2 Function
by: Henning Willers, et al.
Published: (2008-01-01)

Congenital ichthyosis patient with squamous cell carcinoma of the skin who received concurrent chemoradiation: A case report
by: Alberto Cerra-Franco, MD, et al.
Published: (2018-01-01)

The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function
by: Yugo Hirata, et al.
Published: (2019-07-01)

Post chemoradiation re-staging of rectal cancer using MRI
by: Patel, Uday
Published: (2012)

Rectal cancer and chemoradiation in Iraq: systematic review and meta-analysis
by: Ahmed Salih Alshewered, et al.
Published: (2019-10-01)

Successful embolization of a enterocutaneous fistula tract with Onyx 34 following low anterior resection for rectal cancer
by: Hamza Rahimi, BA, et al.
Published: (2018-06-01)

Primary urachal adenocarcinoma treated effectively with surgery and post operative chemoradiation therapy: Case Report with review of the literature
by: Fadila Kouhen, MD, et al.
Published: (2021-08-01)

Microcystic Adnexal Carcinoma of the Face Treated With Definitive Chemoradiation: A Case Report and Review of the Literature
by: Daniel W. Kim, MD, MBA, et al.
Published: (2020-03-01)

Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial
by: C.S. Wong, et al.
Published: (2021-09-01)

Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer
by: Margaret Montovano, MA, et al.
Published: (2021-05-01)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
by: Michael N. Corradetti, MD, PhD, et al.
Published: (2019-10-01)

Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal.
by: Rebecca A Boisvert, et al.
Published: (2013-01-01)

Reducing Hospitalizations and Emergency Department Visits in Patients With Venous Thromboembolism Using a Multicomponent Care Transition Intervention
by: Alok Kapoor MD, MSc, et al.
Published: (2020-01-01)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
by: Iacopino Bruno, et al.
Published: (2009-04-01)

Neoadjuvant chemoradiation with capcitabine and celecoxib in stage II and III rectal adenocarcinoma
by: Aghili M, et al.
Published: (2010-10-01)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2017-03-01)

Predictors of complete response and disease recurrence following chemoradiation for rectal cancer
by: Danielle S. Bitterman, et al.
Published: (2015-12-01)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
by: Oliver J. Ott, et al.
Published: (2021-03-01)

A Description of Patient and Provider Experience and Clinical Outcomes After Heart Failure Shared Medical Appointment
by: Lisa B Cohen PharmD, et al.
Published: (2017-12-01)

COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice
by: Ashish Kataria, MD, et al.
Published: (2020-08-01)